Sex | Age | Whole population | Exposure groups* (risk at baseline) n (%); mean [sd] | ||||
---|---|---|---|---|---|---|---|
Low CVR | Low-intermediate CVR | High-intermediate CVR | High CVR | Previous vascular disease | |||
Women | 50,55 | 0.39 (0.36–0.43) | 0.37 (0.34–0.40) | 0.62 (0.44–0.88) | 1.17 (0.68–2.01) | 1.70 (0.81–3.56) | 0.96 (0.60–1.54) |
55,60 | 1.08 (1.03–1.14) | 1.00 (0.94–1.05) | 1.44 (1.24–1.67) | 1.79 (1.38–2.33) | 2.33 (1.66–3.26) | 2.28 (1.81–2.89) | |
60,65 | 3.16 (3.07–3.24) | 2.93 (2.84–3.02) | 3.62 (3.35–3.92) | 4.15 (3.62–4.75) | 4.90 (4.14–5.80) | 5.33 (4.74–5.99) | |
65,70 | 7.22 (7.07–7.37) | 6.87 (6.71–7.03) | 7.77 (7.32–8.23) | 8.86 (8.03–9.78) | 8.28 (7.19–9.54) | 9.88 (9.14–10.68) | |
70,75 | 14.51 (14.29–14.73) | 14.10 (13.87–14.34) | 14.79 (14.06—15.55) | 15.06 (13.68–16.59) | 16.27 (14.10–18.77) | 18.15 (17.29–19.06) | |
All | 4.79 (4.74–4.84) | 4.37 (4.32–4.42) | 5.86 (5.65–6.08) | 6.51 (6.10–6.94) | 6.92 (6.34–7.57) | 10.30 (9.91–10.70) | |
Men | 50,55 | 0.45 (0.41–0.49) | 0.41 (0.37–0.46) | 0.52 (0.41–0.67) | 0.40 (0.23–0.71) | 0.62 (0.30–1.30) | 0.80 (0.57–1.13) |
55,60 | 1.07 (1.01–1.14) | 0.93 (0.86–1.01) | 1.05 (0.91–1.22) | 1.10 (0.87–1.40) | 1.64 (1.26–2.14) | 2.11 (1.79–2.49) | |
60,65 | 2.79 (2.68–2.89) | 2.44 (2.30–2.58) | 2.80 (2.60–3.02) | 2.96 (2.65–3.31) | 3.05 (2.68–3.48) | 3.96 (3.60–4.36) | |
65,70 | 5.84 (5.68–6.01) | 5.37 (5.10–5.66) | 5.37 (5.07–5.69) | 5.51 (5.11–5.95) | 6.39 (5.93–6.89) | 7.70 (7.20–8.23) | |
70,75 | 11.88 (11.64–12.14) | 11.39 (10.83–11.98) | 10.99 (10.51–11.49) | 11.15 (10.61–11.73) | 11.71 (11.19–12.26) | 14.72 (14.05–15.41) | |
All | 3.95 (3.89–4.01) | 2.22 (2.15–2.29) | 4.29 (4.13–4.46) | 5.72 (5.50–5.96) | 7.33 (7.05–7.61) | 7.27 (7.03–7.52) |